Salvage therapy for progressive, treatment-refractory or recurrent pediatric medulloblastoma: a systematic review protocol

BACKGROUND: Central nervous system tumors remain the leading cause of cancer-related mortality amongst children with solid tumors, with medulloblastoma (MB) representing the most common pediatric brain malignancy. Despite best current therapies, patients with recurrent MB experience have an alarming...

Descripción completa

Detalles Bibliográficos
Autores principales: Adile, Ashley A., Kameda-Smith, Michelle M., Bakhshinyan, David, Banfield, Laura, Salim, Sabra K., Farrokhyar, Forough, Fleming, Adam J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055028/
https://www.ncbi.nlm.nih.gov/pubmed/32127049
http://dx.doi.org/10.1186/s13643-020-01307-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055028/
https://www.ncbi.nlm.nih.gov/pubmed/32127049
http://dx.doi.org/10.1186/s13643-020-01307-8

Ejemplares similares